Atlas Trials

Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum

Clinical trial NCT04274166 · WITHDRAWN

Trial details

NCT number
NCT04274166
Sponsor
Wake Forest University Health Sciences
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pyoderma Gangrenosum
Start date
2021-05-01
Primary completion
2021-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.